Skip to main content

and
  1. Article

    Open Access

    Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

    Lauren K. Shea, Kazuhito Honjo, David T. Redden, Edlue Tabengwa in Blood Cancer Journal (2019)